G. Prashanth

Complete Clinical, Histopathologic and Molecular Remission of Primary Myelofibrosis with Long-Term Treatment with the JAK1/2 Inhibitor Ruxolitinib

D. Niederwieser, U. Siebolts, H. Al-Ali, 2014 .